SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 68 filers reported holding SYNDAX PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,645,507 | +77.4% | 388,809 | +155.8% | 0.13% | +91.4% |
Q2 2023 | $3,181,465 | +833.0% | 152,005 | +891.9% | 0.07% | +438.5% |
Q4 2020 | $341,000 | +321.0% | 15,324 | +53.2% | 0.01% | +62.5% |
Q3 2018 | $81,000 | -63.0% | 10,000 | -36.3% | 0.01% | -82.6% |
Q2 2017 | $219,000 | – | 15,689 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital Management LP | 1,025,000 | $19,588,000 | 3.91% |
Ghost Tree Capital, LLC | 575,000 | $10,988,000 | 3.21% |
Avidity Partners Management LP | 4,823,400 | $92,175,000 | 2.04% |
BVF INC/IL | 2,486,429 | $47,516,000 | 1.85% |
FRAZIER MANAGEMENT LLC | 1,188,135 | $22,705,000 | 1.82% |
Nantahala Capital Management | 2,657,159 | $50,778,000 | 1.60% |
Boxer Capital, LLC | 2,287,782 | $43,720,000 | 1.53% |
ACUTA CAPITAL PARTNERS, LLC | 206,126 | $3,939,000 | 1.39% |
SPHERA FUNDS MANAGEMENT LTD. | 750,603 | $14,344,000 | 1.20% |
PFM Health Sciences, LP | 1,856,738 | $35,482,000 | 1.04% |